Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-28

Clinical Trial Update: Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial is evaluating azathioprine versus methotrexate as part of combination therapy with adalimumab in Crohn's disease. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)
  • Azathioprine (azathioprine)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Crohn Disease, Azathioprine | Phase 3 | Status: RECRUITING